- Home
- Publications
- Publication Search
- Publication Details
Title
Fcγ receptor pathways during active and passive immunization
Authors
Keywords
-
Journal
IMMUNOLOGICAL REVIEWS
Volume 268, Issue 1, Pages 88-103
Publisher
Wiley
Online
2015-10-26
DOI
10.1111/imr.12343
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect
- (2015) David J. DiLillo et al. CELL
- Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy
- (2015) Taia T. Wang et al. CELL
- Fcγ receptors: genetic variation, function, and disease
- (2015) Chantal E. Hargreaves et al. IMMUNOLOGICAL REVIEWS
- Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
- (2015) Marina Caskey et al. NATURE
- Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs
- (2015) Benjamin M. Fiebiger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis for binding of human IgG1 to its high-affinity human receptor FcγRI
- (2015) Masato Kiyoshi et al. Nature Communications
- Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
- (2014) Stylianos Bournazos et al. CELL
- Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice
- (2014) Ariel Halper-Stromberg et al. CELL
- Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity
- (2014) Stylianos Bournazos et al. JOURNAL OF CLINICAL INVESTIGATION
- Structural Characterization of Anti-Inflammatory Immunoglobulin G Fc Proteins
- (2014) Alysia A. Ahmed et al. JOURNAL OF MOLECULAR BIOLOGY
- Type I and type II Fc receptors regulate innate and adaptive immunity
- (2014) Andrew Pincetic et al. NATURE IMMUNOLOGY
- Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo
- (2014) David J DiLillo et al. NATURE MEDICINE
- Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
- (2014) Valentin Goede et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy
- (2014) A. Hiatt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Isotype Switching Increases Efficacy of Antibody Protection against Staphylococcal Enterotoxin B-Induced Lethal Shock and Staphylococcus aureus Sepsis in Mice
- (2014) A. K. Varshney et al. mBio
- Immune Modulation in Cancer with Antibodies
- (2013) David B. Page et al. Annual Review of Medicine
- A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer
- (2013) James D Mellor et al. Journal of Hematology & Oncology
- IgG2 Fc structure and the dynamic features of the IgG CH2–CH3 interface
- (2013) Alexey Teplyakov et al. MOLECULAR IMMUNOLOGY
- Effect of Palivizumab Prophylaxis on Subsequent Recurrent Wheezing in Preterm Infants
- (2013) S. Yoshihara et al. PEDIATRICS
- HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice
- (2013) J. A. Horwitz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- General mechanism for modulating immunoglobulin effector function
- (2013) P. Sondermann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibodies in HIV-1 Vaccine Development and Therapy
- (2013) F. Klein et al. SCIENCE
- Elicitation of broadly reactive antibodies against glycan-modulated neutralizing V3 epitopes of HIV-1 by immune complex vaccines
- (2013) Rajnish Kumar et al. VACCINE
- Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb
- (2013) Xiangguo Qiu et al. Scientific Reports
- Revisiting the Role of Glycosylation in the Structure of Human IgG Fc
- (2012) M. Jack Borrok et al. ACS Chemical Biology
- Novel roles for the IgG Fc glycan
- (2012) Robert M. Anthony et al. Annals of the New York Academy of Sciences
- A Blueprint for HIV Vaccine Discovery
- (2012) Dennis R. Burton et al. Cell Host & Microbe
- B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo
- (2012) Inessa Schwab et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A Serotype 3 Pneumococcal Capsular Polysaccharide-Specific Monoclonal Antibody Requires Fcγ Receptor III and Macrophages To Mediate Protection against Pneumococcal Pneumonia in Mice
- (2012) Sarah Weber et al. INFECTION AND IMMUNITY
- HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
- (2012) Florian Klein et al. NATURE
- Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape
- (2012) Penny L Moore et al. NATURE MEDICINE
- A mouse model for HIV-1 entry
- (2012) J. Pietzsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mouse model recapitulating human Fc receptor structural and functional diversity
- (2012) P. Smith et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal structure of IgE bound to its B-cell receptor CD23 reveals a mechanism of reciprocal allosteric inhibition with high affinity receptor Fc RI
- (2012) B. Dhaliwal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's)
- (2011) Cécile Espy et al. ARTHRITIS AND RHEUMATISM
- Basis of the Intrinsic Flexibility of the Cε3 Domain of IgE
- (2011) Susmita Borthakur et al. BIOCHEMISTRY
- Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway
- (2011) Robert M. Anthony et al. NATURE
- Antibody-based protection against HIV infection by vectored immunoprophylaxis
- (2011) Alejandro B. Balazs et al. NATURE
- Analysis of the antibody structure based on high-resolution crystallographic studies
- (2011) Jo Erika T. Narciso et al. New Biotechnology
- IgE-Mediated Enhancement of CD4+ T Cell Responses in Mice Requires Antigen Presentation by CD11c+ Cells and Not by B Cells
- (2011) Frida Henningsson et al. PLoS One
- Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose
- (2011) C. Ferrara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibitory Fc Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies
- (2011) F. Li et al. SCIENCE
- A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
- (2011) D. Corti et al. SCIENCE
- Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation
- (2011) Rajnish Kumar et al. VACCINE
- Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid
- (2010) Hans U. Scherer et al. ARTHRITIS AND RHEUMATISM
- Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies
- (2010) H. M. Horton et al. BLOOD
- Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response
- (2010) R. Abes et al. BLOOD
- A requirement for FcγR in antibody-mediated bacterial toxin neutralization
- (2010) Nareen Abboud et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques
- (2010) Cherie T Ng et al. NATURE MEDICINE
- Fc RIV deletion reveals its central role for IgG2a and IgG2b activity in vivo
- (2010) F. Nimmerjahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab
- (2009) S. P. Hilchey et al. BLOOD
- Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity
- (2009) Akito Natsume et al. CANCER SCIENCE
- Functional and clinical consequences of Fc receptor polymorphic and copy number variants
- (2009) S. Bournazos et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
- (2009) Frédéric Bibeau et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm
- (2009) M. D. Simek et al. JOURNAL OF VIROLOGY
- Raxibacumab for the Treatment of Inhalational Anthrax
- (2009) Thi-Sau Migone et al. NEW ENGLAND JOURNAL OF MEDICINE
- The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120
- (2009) Catarina E. Hioe et al. VACCINE
- Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study
- (2009) Fleur E van de Geijn et al. ARTHRITIS RESEARCH & THERAPY
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimization of antibody binding to Fc RIIa enhances macrophage phagocytosis of tumor cells
- (2008) J. O. Richards et al. MOLECULAR CANCER THERAPEUTICS
- In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner
- (2008) H. Albert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of a receptor required for the anti-inflammatory activity of IVIG
- (2008) R. M. Anthony et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc
- (2008) R. M. Anthony et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now